http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015028024-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dab9738ced0fc2b804dfea81ae7e417 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72 |
filingDate | 2014-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_928f5df13a41b4a5b62c68e259c04d27 |
publicationDate | 2015-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2015028024-A |
titleOfInvention | Sprayable composition of quaternary ammonium muscarinic receptor antagonist |
abstract | Provided is a kit for treating, preventing, or improving one or more symptoms of bronchoconstrictive disorder. A sprayable composition for the treatment of a disorder associated with bronchoconstriction or amelioration of one or more symptoms comprising (a) a nebulizer, (ii) 0.0005% -5 based on ammonium Quaternary ammonium muscarinic receptor antagonist at a concentration by weight, (b) formoterol free base at a concentration of 5 μg / mL to 2 mg / mL, (c) a pharmacologically acceptable fluid, and (d) a pharmacology Wherein the pH of the composition is adjusted to 2.0-4.5 with acid and the quaternary ammonium muscarinic receptor antagonist is dissolved in the fluid. And the composition optionally comprises pharmacologically acceptable complexing agents, stabilizers, pharmacologically acceptable cosolvents, or other pharmacologically acceptable adjuvants and additives. Kit, including composition. [Selection figure] None |
priorityDate | 2006-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 443.